Trial Profile
An open-label study of the safety of Fuzeon plus free choice of antiretroviral therapy in patients with advanced HIV disease and previous multidrug experience who have no viable treatment regimen.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Dec 2010
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Roche
- 26 Feb 2010 New trial record